European Journal of Surgical Oncology
Volume 36 , Pages S36-S43 , September 2010

Variation in management of early breast cancer in the Netherlands, 2003–2006

  • L.N. van Steenbergen

      Affiliations

    • Comprehensive Cancer Centre South, Eindhoven, The Netherlands
    • ,
  • L.V. van de Poll-Franse

      Affiliations

    • Comprehensive Cancer Centre South, Eindhoven, The Netherlands
    • Center of Research on Psychology in Somatic diseases (CoRPS), Tilburg University, Tilburg, The Netherlands
    • Corresponding Author InformationCorresponding author. Comprehensive Cancer Centre South, PO Box 231, 5600 AE Eindhoven, The Netherlands. Tel.: +31 40 2971616; fax: +31 40 2971610.
    • ,
  • M.W.J.M. Wouters

      Affiliations

    • Dept. of Surgery, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
    • ,
  • M.L.E.A. Jansen-Landheer

      Affiliations

    • Comprehensive Cancer Centre Amsterdam, Amsterdam, The Netherlands
    • ,
  • J.W.W. Coebergh

      Affiliations

    • Comprehensive Cancer Centre South, Eindhoven, The Netherlands
    • Dept. of Public Health, Erasmus University Medical Centre, Rotterdam, The Netherlands
    • ,
  • H. Struikmans

      Affiliations

    • Dept. of Radiotherapy, Leiden University Medical Centre, Leiden, The Netherlands
    • Dept. of Radiotherapy, Medical Centre Haaglanden, The Hague, The Netherlands
    • ,
  • V.C.G. Tjan-Heijnen

      Affiliations

    • Division of Medical Oncology, Dept. of Internal Medicine, GROW – School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands
    • ,
  • C.J.H. van de Velde

      Affiliations

    • Dept. of Surgery, Leiden University Medical Centre, Leiden, The Netherlands

,Accepted 8 June 2010.

References 

  1. www.ikcnet.nl.accessedon03-04-2010
  2. www.oncoline.nl.accessedon18-04-2010
  3. van Lanschot JJ, Hulscher JB, Buskens CJ, Tilanus HW, ten Kate FJ, Obertop H. Hospital volume and hospital mortality for esophagectomy. Cancer. 2001;91(8):1574–1578
  4. Wouters MW, Wijnhoven BP, Karim-Kos HE, et al. High-volume versus low-volume for esophageal resections for cancer: the essential role of case-mix adjustments based on clinical data. Ann Surg Oncol. 2008;15(1):80–87
  5. Begg CB, Cramer LD, Hoskins WJ, Brennan MF. Impact of hospital volume on operative mortality for major cancer surgery. JAMA. 1998;280(20):1747–1751
  6. Finlayson EV, Goodney PP, Birkmeyer JD. Hospital volume and operative mortality in cancer surgery: a national study. Arch Surg. 2003;138(7):721–725discussion 6
  7. Roohan PJ, Bickell NA, Baptiste MS, Therriault GD, Ferrara EP, Siu AL. Hospital volume differences and five-year survival from breast cancer. Am J Public Health. 1998;88(3):454–457
  8. Bilimoria KY, Bentrem DJ, Feinglass JM, et al. Directing surgical quality improvement initiatives: comparison of perioperative mortality and long-term survival for cancer surgery. J Clin Oncol. 2008;26(28):4626–4633
  9. Cheung MC, Hamilton K, Sherman R, et al. Impact of teaching facility status and high-volume centers on outcomes for lung cancer resection: an examination of 13,469 surgical patients. Ann Surg Oncol. 2009;16(1):3–13
  10. Chaudhry R, Goel V, Sawka C. Breast cancer survival by teaching status of the initial treating hospital. CMAJ. 2001;164(2):183–188
  11. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;365(9472):1687–1717
  12. Giordano SH, Duan Z, Kuo YF, Hortobagyi GN, Goodwin JS. Use and outcomes of adjuvant chemotherapy in older women with breast cancer. J Clin Oncol. 2006;24(18):2750–2756
  13. Visser O, Siesling S, van Dijck J. Incidence of cancer in the Netherlands 1999/2000. Utrecht: Vereniging van Integrale Kankercentra; 2003;
  14. UICC . TNM classification of malignant tumours. 6th ed.. New York: Wiley-Liss; 2002;
  15. Schouten LJ, Hoppener P, van den Brandt PA, Knottnerus JA, Jager JJ. Completeness of cancer registration in Limburg, The Netherlands. Int J Epidemiol. 1993;22(3):369–376
  16. www.prismant.nl.accessedon27-08-2009
  17. Arriagada R, Le MG, Guinebretiere JM, Dunant A, Rochard F, Tursz T. Late local recurrences in a randomised trial comparing conservative treatment with total mastectomy in early breast cancer patients. Ann Oncol. 2003;14(11):1617–1622
  18. Voogd AC, Nielsen M, Peterse JL, et al. Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials. J Clin Oncol. 2001;19(6):1688–1697
  19. Collins ED, Moore CP, Clay KF, et al. Can women with early-stage breast cancer make an informed decision for mastectomy?. J Clin Oncol. 2009;27(4):519–525
  20. Katipamula R, Degnim AC, Hoskin T, et al. Trends in mastectomy rates at the Mayo clinic rochester: effect of surgical year and preoperative magnetic resonance imaging. J Clin Oncol. 2009;27(25):4082–4088
  21. McGuire KP, Santillan AA, Kaur P, et al. Are mastectomies on the rise? A 13-year trend analysis of the selection of mastectomy versus breast conservation therapy in 5865 patients. Ann Surg Oncol. 2009;16(10):2682–2690
  22. Ververs JM, Roumen RM, Vingerhoets AJ, et al. Risk, severity and predictors of physical and psychological morbidity after axillary lymph node dissection for breast cancer. Eur J Cancer. 2001;37(8):991–999
  23. Voogd AC, Ververs JM, Vingerhoets AJ, Roumen RM, Coebergh JW, Crommelin MA. Lymphoedema and reduced shoulder function as indicators of quality of life after axillary lymph node dissection for invasive breast cancer. Br J Surg. 2003;90(1):76–81
  24. Roumen RM, Valkenburg JG, Geuskens LM. Lymphoscintigraphy and feasibility of sentinel node biopsy in 83 patients with primary breast cancer. Eur J Surg Oncol. 1997;23(6):495–502
  25. Ho VK, van der Heiden-van der Loo M, Rutgers EJ, et al. Implementation of sentinel node biopsy in breast cancer patients in the Netherlands. Eur J Cancer. 2008;44(5):683–691
  26. Veronesi U, Paganelli G, Galimberti V, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet. 1997;349(9069):1864–1867
  27. Cox CE, Bass SS, McCann CR, et al. Lymphatic mapping and sentinel lymph node biopsy in patients with breast cancer. Annu Rev Med. 2000;51:525–542
  28. Schijven MP, Vingerhoets AJ, Rutten HJ, et al. Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy. Eur J Surg Oncol. 2003;29(4):341–350
  29. Aebi S, Pagani O. Treatment of premenopausal women with early breast cancer: old challenges and new opportunities. Drugs. 2007;67(10):1393–1401
  30. Harlan LC, Clegg LX, Abrams J, Stevens JL, Ballard-Barbash R. Community-based use of chemotherapy and hormonal therapy for early-stage breast cancer: 1987–2000. J Clin Oncol. 2006;24(6):872–877
  31. Sukel MP, van de Poll-Franse LV, Nieuwenhuijzen GA, et al. Substantial increase in the use of adjuvant systemic treatment for early stage breast cancer reflects changes in guidelines in the period 1990-2006 in the southeastern Netherlands. Eur J Cancer. 2008;44:1846–1854
  32. Du X, Goodwin JS. Patterns of use of chemotherapy for breast cancer in older women: findings from medicare claims data. J Clin Oncol. 2001;19(5):1455–1461
  33. Laine C, Sox HC. Does practice really make perfect?. Ann Intern Med. 2003;139(8):696–698
  34. Louwman WJ, Janssen-Heijnen ML, Houterman S, et al. Less extensive treatment and inferior prognosis for breast cancer patient with comorbidity: a population-based study. Eur J Cancer. 2005;41(5):779–785

☆ Study performed by the ‘Quality of cancer care’ taskforce of the Signalling Committee Cancer of the Dutch Cancer Society (the committees full report is available on www.kwfkankerbestrijding.nl).

PII: S0748-7983(10)00197-6

doi: 10.1016/j.ejso.2010.06.021

European Journal of Surgical Oncology
Volume 36 , Pages S36-S43 , September 2010

Article Tools

* Image Usage & Resolution